Bloomberg News (8/5, Feeley, Milford) reported, "AstraZeneca Plc, the UK's second-biggest drugmaker, agreed to pay about $55 million to settle around 5,500 lawsuits related to side effects of the antipsychotic Seroquel [quetiapine], people familiar with the accords said." AstraZeneca's "5,500 settlements include 4,000 that AstraZeneca acknowledged in a July 29 regulatory filing as reported by Bloomberg News (7/31, Milford, Feeley). The claims were settled through mediation, and the company said it will “keep terms of the agreements confidential." Bloomberg News noted that "the consolidated Seroquel case is In re Seroquel Products Litigation, 06-MD-01769, US District Court, Middle District of Florida (Orlando)."
